Skip to main content
ENSG
NASDAQ Life Sciences

Ensign Group Issues FY26 EPS Guidance of $7.48-$7.62

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
7
Price
$186.69
Mkt Cap
$10.905B
52W Low
$125.325
52W High
$218
Market data snapshot near publication time

summarizeSummary

Ensign Group has provided its full-year EPS guidance, projecting earnings per share to be between $7.48 and $7.62. This new guidance offers a forward-looking view into the company's expected financial performance for the fiscal year. While the headline itself does not provide context on how this guidance compares to analyst consensus or previous company forecasts, it is a material piece of information for traders and investors. Professional traders will use this data to update their financial models and adjust their investment theses and positioning for ENSG. The next catalyst to watch will be how this guidance is received by the market and any subsequent analyst revisions.

At the time of this announcement, ENSG was trading at $186.69 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $125.33 to $218.00. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


show_chartPrice Chart

Share this article

Copied!

feed ENSG - Latest Insights

ENSG
Apr 30, 2026, 4:11 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
ENSG
Feb 04, 2026, 4:04 PM EST
Filing Type: 10-K
Importance Score:
8